Skip to content
Screener

Mirion Technologies MIR Cancer care — Total revenues

Other product segments

Nuclear power
$118.1M+43.8%
Labs and research
$29.1M+6.2%
Other
$17.8M-44.7%

Similar metrics at other companies

PBH
PBHOral Care — Total revenues
$22.36M+3.0%
ALN
ALNYTotal Rare — Total revenues
$141.89M+11.1%
PBH
PBHEye & Ear Care — Total revenues
$32.98M+2.1%
Atlassian logo
TEAMData Center — Total revenues
$461.94M+21.3%
TBR
TBRGPatient Care — Total revenues
$33M+6.2%
Bausch + Lomb logo
BLCOVision Care — Total revenues
$784M+4.1%

Other financials

Income statement

See full
Revenue$266.8M+19.7%
Gross profit$133.1M+29.9%
Operating income$17.9M+80.8%
Net income$7.7M-7.2%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$421.6M+60.3%
Total debt$476.6M-0.1%
Total equity$1.8B+24.9%
Total assets$3.5B+28.6%

Cash flow

See full
Operating cash flow$58.5M+372%
CapEx$10.4M+18.2%
Free cash flow$48.1M+1,236%

Valuation

See full
Market cap$3.74B-24.7%
Enterprise value$3.8B-26.7%
P/E152.7×
P/S3.7×-2.0×

Profitability

See full
Gross margin48%+1.3pp
Operating margin5.3%+0.1pp
Net margin2.4%
FCF margin13%+3.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.1×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Mirion Technologies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Mirion Technologies’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050604
Line itemRevenues / Three Months Ended June 30, 2026Revenues / Three Months Ended June 30, 2025Revenues / Six Months Ended June 30, 2026Revenues / Six Months Ended June 30, 2025
Nuclear & Safety segment:
Nuclear$118.1$82.1$243.9$166.3
Labs and research29.127.457.454.2
Other39.032.270.454.6
Medical segment:
Cancer care62.862.2118.1111.1
Other17.819.034.638.7
Total Revenues$266.8$222.9$524.4$424.9

Item 1. Financial Statements (Unaudited)

FAQ

What is Mirion Technologies's cancer care — total revenues?
Mirion Technologies (MIR) reported cancer care — total revenues of $62.8M in Q2 2026.
How has Mirion Technologies's cancer care — total revenues changed year-over-year?
Mirion Technologies's cancer care — total revenues increased by 1.0% year-over-year, from $62.2M to $62.8M.
What is the long-term trend for Mirion Technologies's cancer care — total revenues?
Over 3 years (2022 to 2025), Mirion Technologies's cancer care — total revenues has grown at a 5.1% compound annual growth rate (CAGR), from $206M to $239.1M.
What does cancer care — total revenues mean?
This metric represents the total gross revenue generated by the company's cancer care segment, which focuses on radiation oncology quality assurance and patient safety solutions. It reflects the market demand for specialized medical technologies used in cancer treatment and diagnostic workflows. Growth in this figure indicates successful commercial adoption of clinical solutions and expansion within the oncology healthcare market.

Ask your AI about Mirion Technologies's cancer care — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude